Compare Mutual Funds

Pros

-

5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Among most bought funds within the category.

Among most bought funds within the category.

Cons

-

-

INDMoney rank
-
2/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

4 Years 7 Months

7 Years 11 Months

Fund AUM

₹230 Cr

₹6669 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.47%

0.86%

Exit Load

0.5%

1%

Benchmark Index

Nifty Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

43

43

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(11.8%)
  2. Divi's Laboratories Ltd(8.77%)
  3. Apollo Hospitals Enterprise Ltd(6.6%)
  4. Max Healthcare Institute Ltd Ordinary Shares(5.5%)
  5. Torrent Pharmaceuticals Ltd(5.28%)
  1. Sun Pharmaceuticals Industries Ltd(11.76%)
  2. Cipla Ltd(9.23%)
  3. Mankind Pharma Ltd(7.01%)
  4. Biocon Ltd(6.08%)
  5. Divi's Laboratories Ltd(6.06%)
No of Sectors

4

2

Top 3 Sectors
  1. Health(93.11%)
  2. Basic Materials(4.8%)
  3. Financial Services(1.26%)
  1. Health(98.81%)
  2. Basic Materials(1.19%)
Equity %

99.2%

96.76%

Debt %

-

-

P/E

41.88

33.84

P/B

6.07

4.23

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

9.02%

8.89%

3-Month Return

11.19%

11.09%

6-Month Return

5.05%

4.45%

1-Year Return

7.88%

11.97%

3-Year Return

24.4%

30.67%

5-Year Return

-

17.41%

Sharpe

0.89

1.2

Alpha

-0.48

2.84

Beta

0.93

0.97

Standard Deviation

16.77

16.85

Information Ratio

-0.36

0.73

Description

ITI Pharma and Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Dhimant Shah

Dharmesh Kakkad, Sharmila D’mello

Most Popular Comparisons